In the latest market close, Organon (OGN) reached $19.17, with a +0.74% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 0.4% for the day. On the other ...

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Organon & Co (OGN) stock saw a decline, ending the day at $19.66 which represents a decrease of $-0.06 or -0.30% from the prior close of $19.72. The stock opened at $19.8 and touched a low of $19.51 ...

Organon shares have stabilized in recent times, with gradual debt reduction and structural growth allowing for a valuation re ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

GET MORE AI-GENERATED SIGNALS: September 21, 2024, 08:24 am ET, BY Jake B.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

Organon & Co (NYSE:OGN) has agreed to acquire Roivant Sciences Ltd’s (NASDAQ:ROIV) Dermavant Sciences Ltd, which is focused ...

Organon & Co (OGN) stock saw a modest uptick, ending the day at $20.88 which represents a slight increase of $0.41 or 2.00% from the prior close of $20.47. The stock opened at $20.51 and touched a low ...

Despite posting some strong earnings, the market for Organon & Co.'s ( NYSE:OGN ) stock hasn't moved much. Our analysis... Organon ( NYSE:OGN ) Second Quarter 2024 Results Key Financial Results ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), retaining the price target of ...